HOMOEOPATHY IN UROLITHIASIS.

AN INTERVENTIONAL STUDY TO COMPARE THE EFFECTIVENESS BETWEEN OCIMUM CANUM 3X AND INDIVIDUALIZED HOMOEOPATHIC MEDICINE ON THE PATIENTS HAVING UROLITHIASIS BASED ON THE ASSESSMENT OF USS SCORE: AN OPEN-LABEL RANDOMIZED CONTROLLED TRIAL - nil

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106157

Enrollment

Registered

2026-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N22- Calculus of urinary tract in diseases classified elsewhere

Interventions

Intervention1: Ocimum Canum: Ocimum Canum 3X/ BD/ 4 globules will be administered for 3 months Control Intervention1: individualized homoeopathic medicine: prescribed according to the totality of symp

Eligibility

Inclusion criteria

Inclusion criteria: a. Patients between the ages of 18 and 65 years. b. Size of the urinary stone ranging from 3mm to 10 mm. c. Confirmed diagnosis of renal calculi through ultrasound. d. Both unilateral and bilateral cases of renal calculi will be considered. e. Patients willing to adhere to general lifestyle modifications related to diet and fluid intake during the study period.

Exclusion criteria

Exclusion criteria: a. Severe or advanced cases requiring surgical procedures or orthopaedic corrections of deformities b. Patients with psychiatric diseases c. Cases suffering from uncontrolled systemic illness or life-threatening infections or any other vital organ failure. d. Cases impacted or with stag horn calculi and cases with severe hydronephrosis as per ultrasound findings. e. Gross developmental or structural abnormalities of urinary system (like urethral stricture) f. Substance abuse and or dependence g. Pregnancy, lactation, and women of child bearing potential and not practicing a reliable method of birth control. h. Participants undergoing homoeopathic treatment for any other chronic disease for last 6 months i. Simultaneous participation in any other clinical trial.

Design outcomes

Primary

Measure	Time frame
To compare the mean change in USS score between Individualized Homoeopathic medicine (IHM) and Ocimum Cannum 3X in the treatment of urolithiasis at baseline and after 3 months of intervention.Timepoint: assessed at baseline and after 3 months of intervention.	—

Secondary

Measure	Time frame
1. MONARCH score will be evaluated to assess the causal attribution between the interventions and the clinical outcome of the patients after 3 months of intervention Timepoint: assessed at baseline and after 3 months of intervention.	—

Countries

India

Contacts

Public ContactDR TSERING YANKEY

NATIONAL INSTITUTE OF HOMOEOPATHY

ajith.nih@gov.in9745890190

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026